Combination of an ultrafast TWIST-VIBE Dixon sequence protocol and diffusion-weighted imaging into an accurate easily applicable classification tool for masses in breast MRI.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
May 2020
Historique:
received: 31 07 2019
accepted: 05 12 2019
revised: 18 11 2019
pubmed: 1 2 2020
medline: 3 11 2020
entrez: 1 2 2020
Statut: ppublish

Résumé

This study aimed to develop a tool for the classification of masses in breast MRI, based on ultrafast TWIST-VIBE Dixon (TVD) dynamic sequences combined with DWI. TVD sequences allow to abbreviate breast MRI protocols, but provide kinetic information only on the contrast wash-in, and because of the lack of the wash-out kinetics, their diagnostic value might be hampered. A special focus of this study was thus to maintain high diagnostic accuracy in lesion classification. Sixty-one patients who received breast MRI between 02/2014 and 04/2015 were included, with 83 reported lesions (60 malignant). Our institute's standard breast MRI protocol was complemented by an ultrafast TVD sequence. ADC and peak enhancement of the TVD sequences were integrated into a generalised linear model (GLM) for malignancy prediction. For comparison, a second GLM was calculated using ADC and conventional DCE curve type. The resulting GLMs were evaluated for standard diagnostic parameters. For easy application of the GLMs, nomograms were created. The GLM based on peak enhancement of the TVD and ADC was as equally accurate as the GLM based on conventional DCE and ADC, with no significant differences (sensitivity, 93.3%/93.3%; specificity, 91.3%/87.0%; PPV, 96.6%/94.9%; NPV, 84.0%/83.3%; all, p ≥ 0.315). This study presents a method to integrate ultrafast TVD sequences into a breast MRI protocol, allowing a reduction of the examination time while maintaining diagnostic accuracy. A GLM based on the combination of TVD-derived peak enhancement and ADC provides high diagnostic accuracy, and can be easily applied using a nomogram. • Ultrafast TWIST-VIBE Dixon sequence protocols in combination with diffusion-weighted imaging allow to shorten breast MRI examinations, while diagnostic accuracy is maintained. • Integrating peak enhancement from the TWIST-VIBE Dixon sequence and the apparent diffusion coefficient into a generalised linear model provides a comprehensible image evaluation approach. • This approach is further facilitated by nomograms.

Identifiants

pubmed: 32002644
doi: 10.1007/s00330-019-06608-8
pii: 10.1007/s00330-019-06608-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2761-2772

Références

Clin Breast Cancer. 2016 Jun;16(3):207-11
pubmed: 27108218
J Magn Reson Imaging. 2001 Jun;13(6):821-9
pubmed: 11382939
Ann Intern Med. 2008 Aug 19;149(4):273-5
pubmed: 18711159
J Magn Reson Imaging. 2012 Aug;36(2):483-91
pubmed: 22544731
Eur Radiol. 2008 Jul;18(7):1307-18
pubmed: 18389253
AJR Am J Roentgenol. 2006 Feb;186(2):426-30
pubmed: 16423948
Eur Rev Med Pharmacol Sci. 2016 Oct;20(20):4220-4229
pubmed: 27831654
Eur J Cancer. 2010 May;46(8):1296-316
pubmed: 20304629
Eur Radiol. 2016 Mar;26(3):884-91
pubmed: 26115653
Acad Radiol. 2015 Sep;22(9):1157-62
pubmed: 26152500
J Clin Oncol. 2014 Aug 1;32(22):2304-10
pubmed: 24958821
Rofo. 2011 Feb;183(2):126-35
pubmed: 20830650
Invest Radiol. 2018 Oct;53(10):587-595
pubmed: 29620604
Radiology. 2008 Jan;246(1):58-70
pubmed: 18096529
Lancet Oncol. 2015 Apr;16(4):e173-80
pubmed: 25846097
Eur Radiol. 2014 Sep;24(9):2213-9
pubmed: 24792515
J Am Coll Radiol. 2016 Nov;13(11S):R74-R80
pubmed: 27814819
J Magn Reson Imaging. 2013 Nov;38(5):1033-42
pubmed: 24038452
J Magn Reson Imaging. 2006 Sep;24(3):478-88
pubmed: 16897692
J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21
pubmed: 23940285
Cancer Imaging. 2014 Apr 22;14:11
pubmed: 25608450
Invest Radiol. 2014 Sep;49(9):579-85
pubmed: 24691143
J Magn Reson Imaging. 2012 Sep;36(3):543-60
pubmed: 22903655
Eur J Radiol. 2011 Jan;77(1):185-8
pubmed: 19646836
Eur Radiol. 2012 Feb;22(2):322-30
pubmed: 21913060
J Chem Inf Model. 2015 Jul 27;55(7):1316-22
pubmed: 26099013
Acta Radiol. 2012 Apr 1;53(3):267-9
pubmed: 22334872
AJR Am J Roentgenol. 2011 Jan;196(1):210-7
pubmed: 21178069
BMC Cancer. 2013 Jul 10;13:339
pubmed: 23837641
Eur Radiol. 2020 Jan;30(1):47-56
pubmed: 31359125
AJR Am J Roentgenol. 2015 May;204(5):1120-4
pubmed: 25905951
Oncotarget. 2017 Nov 1;8(69):114360-114370
pubmed: 29371992
Eur Radiol. 2017 May;27(5):1883-1892
pubmed: 27578047
Radiology. 1999 Apr;211(1):101-10
pubmed: 10189459
Magn Reson Med Sci. 2004;3(4):189-97
pubmed: 16093637
J Am Coll Radiol. 2009 Mar;6(3):171-9
pubmed: 19248993
Eur J Radiol. 2016 Apr;85(4):815-23
pubmed: 26971429
Invest Radiol. 2012 Feb;47(2):128-35
pubmed: 21934515
Br J Gen Pract. 2007 May;57(538):404-6
pubmed: 17504593
Radiology. 2019 Dec;293(3):504-520
pubmed: 31592734
Neural Netw. 2004 Dec;17(10):1467-75
pubmed: 15541948
Invest Radiol. 2017 Oct;52(10):574-582
pubmed: 28463932
AJR Am J Roentgenol. 2009 Sep;193(3):861-7
pubmed: 19696303
Eur J Radiol. 2015 Jan;84(1):65-70
pubmed: 25454099
IEEE Trans Med Imaging. 2014 Feb;33(2):225-32
pubmed: 24058020
Clin Breast Cancer. 2016 Jun;16(3):202-6
pubmed: 26738948
J Magn Reson Imaging. 2009 May;29(5):1080-4
pubmed: 19388115
J Magn Reson Imaging. 2011 Oct;34(4):973-82
pubmed: 21769981
Acad Radiol. 2017 Apr;24(4):418-425
pubmed: 27955879
AJR Am J Roentgenol. 2006 Aug;187(2):W152-60
pubmed: 16861504
NMR Biomed. 2009 Jan;22(1):28-39
pubmed: 18654999

Auteurs

Sandra C Peter (SC)

Department of Radiology, Erlangen University Hospital, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany.

Evelyn Wenkel (E)

Department of Radiology, Erlangen University Hospital, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany.

Elisabeth Weiland (E)

Siemens Healthcare GmbH, Allee am Röthelheimpark 2, 91052, Erlangen, Germany.

Matthias Dietzel (M)

Department of Radiology, Erlangen University Hospital, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany.

Rolf Janka (R)

Department of Radiology, Erlangen University Hospital, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany.

Arndt Hartmann (A)

Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.

Julius Emons (J)

Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen - EMN, 91054, Erlangen, Germany.

Michael Uder (M)

Department of Radiology, Erlangen University Hospital, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany.

Stephan Ellmann (S)

Department of Radiology, Erlangen University Hospital, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Maximiliansplatz 3, 91054, Erlangen, Germany. stephan.ellmann@uk-erlangen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH